American Journal of Epidemiology Vol. 120, No. 3: 423-435
Copyright © 1984 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
INCIDENCE OF THYROID CANCER IN WOMEN IN RELATION TO REPRODUCTIVE AND HORMONAL FACTORS1
Reprint requesb to Dr. McTiernan, Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, 1124 Columbia Street, Seattle, WA 98104
Female residentS of western Washington state aged 18–80 years in whom thyrold cancer was diagnosed between January 1974 and December 1979 were interviewed concerning their reproductive histories and their prior use of exogenous estrogens. Their responses were compared with those of a sample of women from the same population, individually matched to cases on tele phone prefix. Use of each of several estrogen-containing preparations was associated with a small increased risk of thyroid cancer; parous women who had ever used a lactation suppressant had 1.7 times the risk of parous nonusers (95% confidence interval, 1.1–2.8); ever users of oral contraceptives had 1.6 times the risk of never users (95% confidence interval, 0.98–2.5); and ever users of postmenopausal estrogens had 1.4 times the risk of never users (95% confidence interval, 0.89–2.3). Among the low risk group of women, i.e., those who had never undergone radiation therapy and who had never had a goiter, a history of one or more pregnancies was also associated with a small increase in the risk of thyrold cancer (relative rlsk = 1.8, 95% confidence interval, 1.1–3.1). However, no increase in risk with increasing duration of use of oral contraceptives or menopausal estrogens or with increasing number of pregnancies was noted. While pregnancy and use of exogenous estrogens have an impact on the production of thyrold-stimulating hormone, their effect on the icidence of thyrold carcinoma, if present at all, appears to be small.
contraceptives, oral; estrogens; goiter; pregnancy; radiation; thyroid neoplasms
1From the Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA, and the Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, WA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C.G. Hannibal, A. Jensen, H. Sharif, and S.K. Kjaer Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study Hum. Reprod., February 1, 2008; 23(2): 451 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Brindel, F. Doyon, F. Rachedi, J.-L. Boissin, J. Sebbag, L. Shan, V. Chungue, L. Y. K. Sun, F. Bost-Bezeaud, P. Petitdidier, et al. Menstrual and Reproductive Factors in the Risk of Differentiated Thyroid Carcinoma in Native Women in French Polynesia: A Population-based Case-Control Study Am. J. Epidemiol., January 15, 2008; 167(2): 219 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Subsection Reports J. Clin. Endocrinol. Metab., August 1, 2007; 92(8_suppl): s8 - s47. [Full Text] [PDF]
|
|
|
|
|
|
M. Abalovich, N. Amino, L. A. Barbour, R. H. Cobin, L. J. De Groot, D. Glinoer, S. J. Mandel, and A. Stagnaro-Green Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., August 1, 2007; 92(8_suppl): s1 - s47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Truong, L. Orsi, D. Dubourdieu, Y. Rougier, D. Hemon, and P. Guenel Role of Goiter and of Menstrual and Reproductive Factors in Thyroid Cancer: A Population-based Case-Control Study in New Caledonia (South Pacific), a Very High Incidence Area Am. J. Epidemiol., June 1, 2005; 161(11): 1056 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Haselkorn, S. L. Stewart, and P. L. Horn-Ross Why Are Thyroid Cancer Rates So High in Southeast Asian Women Living in the United States? The Bay Area Thyroid Cancer Study Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 144 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Sakoda and P. L. Horn-Ross Reproductive and Menstrual History and Papillary Thyroid Cancer Risk: The San Francisco Bay Area Thyroid Cancer Study Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 51 - 57. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. McKean-Cowdin, H. S. Feigelson, R. K. Ross, M. C. Pike, and B. E. Henderson Declining Cancer Rates in the 1990s J. Clin. Oncol., June 11, 2000; 18(11): 2258 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Mack, S. Preston-Martin, L. Bernstein, D. Qian, and M. Xiang Reproductive and Hormonal Risk Factors for Thyroid Cancer in Los Angeles County Females Cancer Epidemiol. Biomarkers Prev., November 1, 1999; 8(11): 991 - 997. [Abstract] [Full Text]
|
|
|
|
|
|
L. Dalla Valle, A. Ramina, S. Vianello, A. Fassina, P. Belvedere, and L. Colombo Potential for Estrogen Synthesis and Action in Human Normal and Neoplastic Thyroid Tissues J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3702 - 3709. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. A. Kerber, J. E. Till, S. L. Simon, J. L. Lyon, D. C. Thomas, S. Preston-Martin, M. L. Rallison, R. D. Lloyd, and W. Stevens A Cohort Study of Thyroid Disease in Relation to Fallout From Nuclear Weapons Testing JAMA, November 3, 1993; 270(17): 2076 - 2082. [Abstract] [PDF]
|
|